[Driver variations in tumor classical signaling pathways and treatment response of immune checkpoint inhibitors].

Jin, J Y; Su, D

Jin, J Y; Su, D.

Afiliação

Jin JY; Department of Pathology, the Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou 310022, China.
Su D; Department of Pathology, the Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou 310022, China.

Zhonghua Bing Li Xue Za Zhi ; 50(7): 840-844, 2021 Jul 08.

Article em Zh | MEDLINE | ID: mdl-34405632

Assuntos

Inibidores de Checkpoint Imunológico; Neoplasias; Humanos; Imunoterapia; Neoplasias/tratamento farmacológico; Transdução de Sinais

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Limite: Humans Idioma: Zh Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google